Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coplan

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Drug and Chemical Toxicology|January 1, 1991
The selective toxicity of medications used in the treatment of AIDS on the CEM human leukemic CD4+ T-cell lineP M Coplan, L L Nolan
Postgraduate Medicine|July 7, 2018
Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent propertiesHui G Cheng, Paul M Coplan
Current Opinion in HIV and AIDS|April 18, 2009
Mathematical models and health economic aspects of microbicidesDavid P Wilson, Paul M Coplan
The Primary Care Companion for CNS Disorders|April 4, 2020
Successful Long-Acting Paliperidone Treatment Following Reversible Risperidone-Induced NeutropeniaPatrick R McGuire, Benjamin M Coplan, Shilpa Puri
Science (New York, N.Y.)|June 26, 2004
Public health. Regulatory challenges in microbicide developmentPaul M Coplan, Mark Mitchnick, Zeda F Rosenberg
The Primary Care Companion for CNS Disorders|July 31, 2020
Delayed Onset of Bupropion-Induced UrticariaShilpa Puri, Benjamin M Coplan, Patrick Ryan McGuire
Journal of Comparative Effectiveness Research|August 23, 2018
Conditional power for assessing population interventionsAlexander M Walker, Paul M Coplan, Daniel C Beachler
Drug and Alcohol Dependence|July 4, 2016
Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin)Howard D Chilcoat, Paul M Coplan, Venkatesh Harikrishnan, et al.
The Journal of Infectious Diseases|February 11, 2000
Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with polyribosylribitol phosphate outer membrane protein complex (PRP-OMPC) or failure to vaccinate with PRP-OMPC?J M Dargan, P M Coplan, K M Kaplan, et al.
Postgraduate Medicine|December 16, 2016
Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system dataNelson E Sessler, Ekaterina Walker, Harsha Chickballapur, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Drug and Chemical Toxicology|January 1, 1991
The selective toxicity of medications used in the treatment of AIDS on the CEM human leukemic CD4+ T-cell lineP M Coplan, L L Nolan
Postgraduate Medicine|July 7, 2018
Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent propertiesHui G Cheng, Paul M Coplan
Current Opinion in HIV and AIDS|April 18, 2009
Mathematical models and health economic aspects of microbicidesDavid P Wilson, Paul M Coplan
The Primary Care Companion for CNS Disorders|April 4, 2020
Successful Long-Acting Paliperidone Treatment Following Reversible Risperidone-Induced NeutropeniaPatrick R McGuire, Benjamin M Coplan, Shilpa Puri
Science (New York, N.Y.)|June 26, 2004
Public health. Regulatory challenges in microbicide developmentPaul M Coplan, Mark Mitchnick, Zeda F Rosenberg
The Primary Care Companion for CNS Disorders|July 31, 2020
Delayed Onset of Bupropion-Induced UrticariaShilpa Puri, Benjamin M Coplan, Patrick Ryan McGuire
Journal of Comparative Effectiveness Research|August 23, 2018
Conditional power for assessing population interventionsAlexander M Walker, Paul M Coplan, Daniel C Beachler
Drug and Alcohol Dependence|July 4, 2016
Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin)Howard D Chilcoat, Paul M Coplan, Venkatesh Harikrishnan, et al.
The Journal of Infectious Diseases|February 11, 2000
Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with polyribosylribitol phosphate outer membrane protein complex (PRP-OMPC) or failure to vaccinate with PRP-OMPC?J M Dargan, P M Coplan, K M Kaplan, et al.
Postgraduate Medicine|December 16, 2016
Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system dataNelson E Sessler, Ekaterina Walker, Harsha Chickballapur, et al.
Pageof 7